Viridian RIA’s Oracle ORCL Stock Holding History

Viridian RIA’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,533	Closed	-$448K	–	64
2021 Q4	$483K	Buy	+5,533	New	+$519K	0.1%	66

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Viridian RIA's ORCL Position: Q1 2022 in Review

Viridian RIA sold out of Oracle (ORCL) in Q1 2022, closing a stake of 5,533 shares — an estimated $448K sold.

Viridian RIA first reported a position in ORCL in Q4 2021 and held it in 1 quarter. The position peaked at $483K in Q4 2021. 2,267 funds tracked by Wall St. Rank hold ORCL as of Q1 2022.

Viridian RIA reported no remaining Oracle position as of Q1 2022 after selling out during the quarter.
Viridian RIA sold 5,533 Oracle shares in Q1 2022, an estimated $448K.
Viridian RIA first reported a position in Oracle in Q4 2021 and held it in 1 quarter.
Viridian RIA's Oracle position peaked at $483K in Q4 2021.
2,267 funds tracked by Wall St. Rank held Oracle as of Q1 2022.

Based on Viridian RIA's 13F filing for Q1 2022, filed 26 Apr 2022.